Scientific Leadership Team
Our distinguished scientific leadership team drives Niagen Bioscience's pioneering NAD+ precursor research through strategic global partnerships, leveraging decades of chemistry and regulatory expertise to advance cellular metabolism science for improved global health.
Andrew Shao, Ph.D.
SVP, Global Regulatory & Scientific Affairs
Dr. Andrew Shao serves as SVP at Niagen Bioscience with Ph.D. from Tufts University and oversees scientific, technical and regulatory functions.
Aron Erickson
VP of Research & Development
Aron Erickson, VP of Research and Development, brings 20 years in small molecule and product development expertise to Niagen Bioscience.
Albert Rembert
VP of Quality & Product Safety
Albert Rembert leads quality at Niagen Bioscience with 25+ years of experience as a Chemical Enginee driving global compliance.
Yasmeen Nkrumah-Elie, Ph.D.
Global Director of External Research at Niagen Bioscience
Dr. Yasmeen Nkrumah-Elie leads global preclinical and clinical research development for Niagen Bioscience, FAMU Ph.D. in Pharmaceuticals Science with experience in molecular nutrition and metabolomics.
Mona Rosene, MS, RD
Global Director, Scientific & Medical Affairs
Mona Rosene, MS, RD, is a nutrition expert leading Scientific & Medical Affairs at Niagen Bioscience, focusing on cellular health and NAD+ research.
Erika Shioya
Global Director of Regulatory Affairs
Erika Shioya directs Global Regulatory Affairs at Niagen Bioscience, UC Berkeley graduate, sustainability advocate, compliance leader.